StockNews.com assumed coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a research report released on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Stock Performance NASDAQ ABIO opened at $3.22 on Monday. ARCA biopharma has a 12 month low of $1.56 and a 12 month high […]
StockNews.com started coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a report released on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Stock Down 6.9 % ARCA biopharma stock opened at $3.25 on Friday. ARCA biopharma has a 52-week low of $1.56 and a 52-week […]
StockNews.com started coverage on shares of ARCA biopharma (NASDAQ:ABIO – Free Report) in a research note issued to investors on Saturday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. ARCA biopharma Stock Up 4.6 % ARCA biopharma stock opened at $3.40 on Friday. ARCA biopharma has a 1-year low of $1.56 and […]
ARCA biopharma, Inc. (NASDAQ:ABIO – Get Free Report) saw some unusual options trading activity on Wednesday. Stock traders acquired 3,817 call options on the company. This is an increase of 10,216% compared to the typical daily volume of 37 call options. Institutional Trading of ARCA biopharma Hedge funds have recently added to or reduced their […]
Newtyn Management LLC reduced its holdings in shares of ARCA biopharma, Inc. (NASDAQ:ABIO – Free Report) by 4.2% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 300,000 shares of the biopharmaceutical company’s stock after selling 13,200 shares during the quarter. Newtyn Management LLC’s […]